| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111508A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | WO2009111471A2 Collagen-derived peptide as biomarker, therapeutic agent and target |
| 09/11/2009 | WO2009111372A2 Methods and devices for monitoring of frying oil quality |
| 09/11/2009 | WO2009111370A2 Monitoring of frying oil quality using combined optical interrogation methods and devices |
| 09/11/2009 | WO2009111338A1 A system and process for separating a material |
| 09/11/2009 | WO2009111316A2 Barriers for facilitating biological reactions |
| 09/11/2009 | WO2009111308A2 A method to assess stability of proteins |
| 09/11/2009 | WO2009111254A2 A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies |
| 09/11/2009 | WO2009111240A1 ANTI-AMYLOID β ACTIVITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN VITRO |
| 09/11/2009 | WO2009111183A1 Surface display of recombinant proteins in lower eukaryotes |
| 09/11/2009 | WO2009111067A2 Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation |
| 09/11/2009 | WO2009111033A2 Detection of biomarkers and biomarker complexes |
| 09/11/2009 | WO2009111020A1 Dual-target biosensor cell assays |
| 09/11/2009 | WO2009110936A2 Antigen retrieval methods for immunohistochemistry |
| 09/11/2009 | WO2009110873A2 Improved viral protein quantification and vaccine quality control therewith |
| 09/11/2009 | WO2009110846A1 Method for determination of affinity and kinetic constants |
| 09/11/2009 | WO2009110614A1 Effector cell function measurement method, measurement kit and measurement system |
| 09/11/2009 | WO2009110577A1 Immunoassay method and kit and developing solution therefor |
| 09/11/2009 | WO2009110517A1 Method for evaluating cancer species |
| 09/11/2009 | WO2009110488A1 Blood collection tube |
| 09/11/2009 | WO2009110473A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection |
| 09/11/2009 | WO2009110383A1 Method for screening of therapeutic agent for cancer |
| 09/11/2009 | WO2009110320A1 X-ray examination device |
| 09/11/2009 | WO2009110279A1 A method for evaluating or selecting agents having preventive or alleviative effects on spots |
| 09/11/2009 | WO2009110215A1 Method for induction of ciliated cell differentiation |
| 09/11/2009 | WO2009110089A1 Instrument for analyzing body fluid |
| 09/11/2009 | WO2009109997A1 Method and device for particle removal and droplet preparation for qualitative and quantitative bioanalysis |
| 09/11/2009 | WO2009109982A1 Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events |
| 09/11/2009 | WO2009109868A1 Microfluidic apparatus and method for measuring thermo-physical properties of a reservoir fluid |
| 09/11/2009 | WO2009109862A2 Improved cancer therapeutics |
| 09/11/2009 | WO2009109860A2 Mutant forms of chlamydia htra |
| 09/11/2009 | WO2009109739A1 Real-time filtration apparatus and associated methods |
| 09/11/2009 | WO2009109676A1 Method and kit for the diagnosis of coagulation disorders |
| 09/11/2009 | WO2009109662A1 Diagnosis of and vaccination against aspergillus fumigatus |
| 09/11/2009 | WO2009109647A1 Method for monitoring a metabolic state by measuring inositol phosphate |
| 09/11/2009 | WO2009109604A1 Method for detection of parvovirus b19 in blood or bone marrow |
| 09/11/2009 | WO2009109557A1 The soluble alpha chain of il- 15 receptor as biomarker for the survival of cancer patients |
| 09/11/2009 | WO2009109420A1 Method for operating a gas sensor |
| 09/11/2009 | WO2009109043A1 Method of assessing mammalian embryo quality |
| 09/11/2009 | WO2009094556A3 Identification of predictive markers of response to dasatinib in human colon cancer |
| 09/11/2009 | WO2009092108A3 Biomarkers for the diagnosis and treatment of pancreatic cancer |
| 09/11/2009 | WO2009090553A3 Compositions and methods of detecting post-stop peptides |
| 09/11/2009 | WO2009088891A8 Screening method for selected amino lipid-containing compositions |
| 09/11/2009 | WO2009086000A3 Biomarkers for trichogenicity |
| 09/11/2009 | WO2009081374A3 Cosmetic use of plakoglobin-type proteins |
| 09/11/2009 | WO2009079481A3 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 09/11/2009 | WO2009076638A3 Compositions and methods relating to characterization and therapeutic application of pristine stem cells |
| 09/11/2009 | WO2009073201A3 Alternate labeling strategies for single molecule sequencing |
| 09/11/2009 | WO2009062160A3 Rantes levels as a diagnostic and therapeutic for acute graft versus host disease |
| 09/11/2009 | WO2009059305A3 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| 09/11/2009 | WO2009058893A3 Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic rnas |
| 09/11/2009 | WO2009045434A3 Inhibitors of staphylococcus aureus sdrd protein attachment to cells and uses therefor |
| 09/11/2009 | WO2009029763A3 Method transfer for automated protein analysis |
| 09/11/2009 | WO2009008381A8 Method of distinguishing prostatic cancer from benign prostatic hypertrophy |
| 09/11/2009 | WO2008150308A3 Bcl-2 proteins for inhibiting cell death or inflammation in mammals |
| 09/11/2009 | WO2008100161A9 Surface plasmon resonance assay for steroids |
| 09/11/2009 | WO2008046107A9 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface |
| 09/11/2009 | WO2007106603A3 Specific labeling of proteins with zinc finger tags and use of zinc-finger-tagged proteins for analysis |
| 09/11/2009 | WO2006052795A3 Methods of inhibiting the activity of hsp90 and/or aryl hydrocarbon receptor |
| 09/11/2009 | WO2006021006A3 Non-human animal models for diabetic complications and their uses |
| 09/11/2009 | WO2004097373A3 Thermoelectric biosensor for analytes in a gas |
| 09/11/2009 | CA2749142A1 Cell, method and kit for conducting an assay for neutralizing antibodies |
| 09/11/2009 | CA2717803A1 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | CA2717763A1 Diagnosing and monitoring depression disorders based on multiple biomarker panels |
| 09/11/2009 | CA2717563A1 Protease assay |
| 09/11/2009 | CA2717483A1 Method of assessing mammalian embryo quality |
| 09/11/2009 | CA2717244A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection |
| 09/11/2009 | CA2717143A1 Methods and devices for monitoring of frying oil quality |
| 09/11/2009 | CA2716950A1 Barriers for facilitating biological reactions |
| 09/11/2009 | CA2716521A1 Anti-amyloid .beta. activity of intravenous immunoglobulin (ivig) in vitro |
| 09/11/2009 | CA2716357A1 Molecular diagnosis and classification of malignant melanoma |
| 09/11/2009 | CA2715212A1 Surface display of recombinant proteins in lower eukaryotes |
| 09/11/2009 | CA2713989A1 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090228996 Means and Methods for influencing Interactions Between Dc-Sign and Dc-Sign Ligands |
| 09/10/2009 | US20090228993 Transgenic Pig With Altered Incretin Function |
| 09/10/2009 | US20090228016 Tibial plateau and/or femoral condyle resection system for prosthesis implantation |
| 09/10/2009 | US20090227795 Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereof |
| 09/10/2009 | US20090227776 Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2009 | US20090227692 Biomarkers for breast cancer |
| 09/10/2009 | US20090227686 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2009 | US20090227606 Methods for Preventing or Treating Acute and Chronic Pain |
| 09/10/2009 | US20090227533 miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227502 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227472 Array systems and components |
| 09/10/2009 | US20090227468 Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes |
| 09/10/2009 | US20090227464 Prognosis determination in ewing sarcoma patients by means of genetic profiling |
| 09/10/2009 | US20090227044 Microchannel Magneto-Immunoassay |
| 09/10/2009 | US20090227043 Fluorescence Resonance Energy Transfer Assay Based on Modified Solid Surface |
| 09/10/2009 | US20090227042 Coustic Concentration Method and Device and a Reaction Method |
| 09/10/2009 | US20090227040 Detection of macromolecular complexes on ultraflat surfaces with harmonic cantilevers |
| 09/10/2009 | US20090227039 Detection and Quantitation of Cyclodextrins |
| 09/10/2009 | US20090227038 Methods of determining skeletal maturity |
| 09/10/2009 | US20090227037 Novel screening method |
| 09/10/2009 | US20090227036 Method of diagnosis of pregnancy-related complications |
| 09/10/2009 | US20090227035 Method and test kit for the determination of iron content of in-use lubricants |